|
UTP14A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.780300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.554800E-01 |
| Normal-vs-Stage2 |
3.688400E-01 |
| Normal-vs-Stage3 |
2.776800E-03 |
| Normal-vs-Stage4 |
7.309700E-02 |
| Stage1-vs-Stage2 |
3.945400E-01 |
| Stage1-vs-Stage3 |
2.919100E-03 |
| Stage1-vs-Stage4 |
7.981900E-02 |
| Stage2-vs-Stage3 |
2.576200E-01 |
| Stage2-vs-Stage4 |
3.865800E-01 |
| Stage3-vs-Stage4 |
9.281200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.136200E-01 |
| Normal-vs-AfricanAmerican |
1.864410E-01 |
| Normal-vs-Asian |
1.704630E-01 |
| Caucasian-vs-AfricanAmerican |
7.468200E-01 |
| Caucasian-vs-Asian |
2.056200E-01 |
| AfricanAmerican-vs-Asian |
3.653200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.287000E-01 |
| Normal-vs-Female |
1.359130E-04 |
| Male-vs-Female |
7.94640000000291E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.612400E-01 |
| Normal-vs-Extreme_Weight |
6.371800E-01 |
| Normal-vs-Obese |
2.184400E-02 |
| Normal-vs-Extreme_Obese |
9.809700E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.860000E-01 |
| Normal_Weight-vs-Obese |
4.129000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.835900E-02 |
| Extreme_Weight-vs-Obese |
5.163700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.728350E-01 |
| Obese-vs-Extreme_Obese |
4.596600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.882200E-03 |
| Normal-vs-Age(41-60Yrs) |
2.176500E-02 |
| Normal-vs-Age(61-80Yrs) |
6.600200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.449400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.320270E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.394100E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.695200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.537500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.182620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.683800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.187200E-01 |
| Normal-VS-Type2 PRCC |
8.674500E-02 |
| Normal-VS-KIRP CIMP |
5.822100E-03 |
| Normal-VS-Unclassified PRCC |
7.836500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.163800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.445900E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.404400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.347700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.812200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.491800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.575000E-01 |
| Normal-vs-N1 |
4.404800E-04 |
| Normal-vs-N2 |
3.443600E-01 |
| N0-vs-N1 |
9.387900E-04 |
| N0-vs-N2 |
1.738970E-01 |
| N1-vs-N2 |
5.626600E-01 |
|
|
